For Precision Health | Drug Discovery | Biomedical Research
Our mission is to transform therapeutics of difficult-to-treat diseases and accelerate discovery of new treatments by unleashing the full potential of CLINICO-OMIC data.
Our Platform
+ All-in-one CLOUD INFRASTRUCTURE for organized data storage and scalable bioinformatics.
+ DYNAMIC REPO of deep-mined, global clinico-multiomic data & annotations for 80+ disease conditions.
+ CONNECTION TO 100+ BIOMEDICAL DATABASES combined with knowledge graph based assess to scientific literature.
+ Full loop BIOINFORMATIC WORKFLOWS with logically pre-configured bioinformatic pipelines in conjunction with curated and proprietary AI scores/ML models.
+ Customizable, bioinformatics focused DATA ANALYTIC LIBRARY.
PRECISION HEALTH
ASSESS THE IMPACT OF EVERY DISEASE VARIANT, CO-LOCATED FROM ALL AVAILABLE biomedical DATASPACE.
Utilize our universal, up-to-date clinical data silo as a searchable knowledgebase for assessing the full impact of every known actionable disease variant in cancers and other genetic diseases.
Employ our end-to-end, fully automated multi-omic analysis workflows and computational infrastructure to infer patient targeted genotyping or more advanced genome wide -omic sequencing data. Develop and deploy custom applications or sophisticated precision therapy models based on your data.
Integrate omic data with other clinical metrics to seamlessly generate detailed, interactive, and intuitive precision reports along with ML guided suggestions for individualized therapy.
In addition, by integrated multi-omic analysis of clinical databases, we identify novel biomarkers for precision therapy and risk stratification of patients. Through this, we aim to create sensitive predictive models and diagnostic tests for cancers and other genetic diseases.
DRUG DISCOVERY & DEVELOPMENT
INTER-CONNECTED ANALYSIS MODULES FOR EVERY STAGE OF PRE-CLINICAL DRUG DISCOVERY AND CLINICAL STAGE DRUG DEVELOPMENT.
Identify new druggable targets, either from your multi-omic data OR by easily searching all available -omic dataspace without any input data.
Seamlessly integrate patient multi-modal and multi-omic data to stratify cohorts for target optimization. Repurpose known drugs or develop novel small molecules using our at-scale, AI guided drug design.
Rapidly develop and test machine learning models for understanding clinical modalities, predicting clinical trial success, or optimizing drug development pipelines.
In parallel, by exploiting our expertise and analytics platform, we are deep mining a rationally selected subset of the vast multi-omic dataspace (e.g., RNA processing, protein structure, missense mutations). By shortlisting intervenable candidates through this mining, we are identifying and validating hitherto unknown druggable targets for difficult-to-treat diseases.
BIOMEDICAL RESEARCH & ASSET DEV.
TOOLS & DATASPACE FOR SUPPORTING COMPLEX BIOINFORMATIC ANALYSIS AND AT-SCALE INFRASTRUCTURE FOR CREATION OF ADVANCED BIOINFORMATIC ASSETS .
Build At-scale tangible outcomes of complexity (databases, custom cloud applications) with the help of our computational infrastructure, and data repositories.
Deeply analyze multi-omic/multi-modal data and convert results into shareable insights (research articles, internal protocols) by employing our cloud-based bioinformatic analysis suite designed for discovery and collaboration. Easily collaborate and share findings across the team.
Utilize our basic research oriented, customized, and iterative Bioinformatics as analysis Service (BaaS) that lets you process, homogenize, and find interpretable explanations in your multi-omic data.
BAINOM-nX is your Global Positioning System (GPS) for clinico-omic data, its analysis, and inference.
In practical terms, BAINOM-nX platform functions as a GPS for precision health, drug discovery and biomedical research – it supports the user through the complex and constantly developing landscape of clinico-omic data – starting from extraction of clinical or biological features – arriving at actionable inferences, suggestions, or tangible outocomes.
Work with us to seamlessly decode intricate clinical and biological patterns at unprecedented depths.